Renal Failure clinical trials
18 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- CAR-T Cell Therapy for Desensitization in Kidney Transplantation
- Shingrix in Renal Transplant Recipients
- Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
- Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
- Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
- Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
- Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
- Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients
- Product Surveillance Registry
- Post-Filter Hematocrit
- Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
- Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
- A Study of the Effect of a Nurse Navigator Program on High Risk Patients
- Worldwide Assessment of Deceased Donor Kidney Utilization
- Analysis of the Virtual Acute Care at Home Experience
- Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
- Empagliflozin in ESKD - A Feasibility Study
- APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Renal Failure” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.